AAAAAA
Results: 51-73/73
Authors:
Fedorak, RN
Gangl, A
Elson, CO
Rutgeerts, P
Schreiber, S
Wild, G
Hanauer, SB
Kilian, A
Cohard, M
LeBeaut, A
Feagan, B
Citation: Rn. Fedorak et al., Recombinant human interleukin 10 in the treatment of patients with mild tomoderately active Crohn's disease, GASTROENTY, 119(6), 2000, pp. 1473-1482
Authors:
Louis, E
Peeters, M
Franchimont, D
Seidel, L
Fontaine, F
Demolin, G
Croes, F
Dupont, P
Davin, L
Omri, S
Rutgeerts, P
Belaiche, J
Citation: E. Louis et al., Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?, CLIN EXP IM, 119(1), 2000, pp. 64-68
Authors:
Ghoos, Y
Geypens, B
Rutgeerts, P
Citation: Y. Ghoos et al., (CO2)-C-13 Breath tests and stable isotopes for investigating gastrointestinal functions, ACT GASTR B, 63(4), 2000, pp. 325-327
Authors:
D'Haens, G
Rutgeerts, P
Citation: G. D'Haens et P. Rutgeerts, Postoperative recurrence of Crohn's disease: Pathophysiology and prevention, INFLAMM B D, 5(4), 1999, pp. 295-303
Authors:
Vandeputte, L
D'Haens, G
Baert, F
Rutgeerts, P
Citation: L. Vandeputte et al., Methotrexate in refractory Crohn's disease, INFLAMM B D, 5(1), 1999, pp. 11-15
Authors:
Geypens, B
Claus, D
Gorris, N
Evenepoel, P
Luypaerts, A
Rutgeerts, P
Ghoos, Y
Citation: B. Geypens et al., Determination of deuterated phenylalanine and tyrosine in egg protein by GCQ, HRC-J HIGH, 22(8), 1999, pp. 465-468
Authors:
Geboes, K
Rutgeerts, P
Citation: K. Geboes et P. Rutgeerts, Dysplasia in inflammatory bowel diseases: Definition and clinical impact, CAN J GASTR, 13(8), 1999, pp. 671-678
Authors:
Bennink, R
Peeters, M
Van den Maegdenbergh, V
Geypens, B
Rutgeerts, P
De Roo, M
Mortelmans, L
Citation: R. Bennink et al., Evaluation of small-bowel transit for solid and liquid test meal in healthy men and women, EUR J NUCL, 26(12), 1999, pp. 1560-1566
Authors:
Den Hond, E
Peeters, M
Hiele, M
Bulteel, V
Ghoos, Y
Rutgeerts, P
Citation: E. Den Hond et al., Effect of glutamine on the intestinal permeability changes induced by indomethacin in humans., ALIM PHARM, 13(5), 1999, pp. 679-685
Authors:
Evenepoel, P
Claus, D
Geypens, B
Hiele, M
Geboes, K
Rutgeerts, P
Ghoos, Y
Citation: P. Evenepoel et al., Amount and fate of egg protein escaping assimilation in the small intestine of humans, AM J P-GAST, 277(5), 1999, pp. G935-G943
Authors:
Simoens, M
Gevers, AM
Rutgeerts, P
Citation: M. Simoens et al., Endoscopic therapy for upper gastrointestinal hemorrhage: A state of the art, HEP-GASTRO, 46(26), 1999, pp. 737-745
Authors:
Geypens, B
Bennink, R
Peeters, M
Evenepoel, P
Mortelmans, L
Maes, B
Ghoos, Y
Rutgeerts, P
Citation: B. Geypens et al., Validation of the lactose-[C-13]ureide breath test for determination of orocecal transit time by scintigraphy, J NUCL MED, 40(9), 1999, pp. 1451-1455
Authors:
Den Hond, E
Hiele, M
Peeters, M
Ghoos, Y
Rutgeerts, P
Citation: E. Den Hond et al., Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease, J PARENT EN, 23(1), 1999, pp. 7-11
Authors:
Present, DH
Rutgeerts, P
Targan, S
Hanauer, SB
Mayer, L
van Hogezand, RA
Podolsky, DK
Sands, BE
Braakman, T
DeWoody, KL
Schaible, TF
van Deventer, SJH
Citation: Dh. Present et al., Infliximab for the treatment of fistulas in patients with Crohn's disease, N ENG J MED, 340(18), 1999, pp. 1398-1405
Authors:
Pena, AS
Meuwissen, SGM
Falke, TJM
Cuesta, MA
Hanauer, SB
Rutgeerts, P
Tremaine, BW
Gassull, MA
Cortot, A
Cohen, Z
Citation: As. Pena et al., Inflammatory bowel disease. A case presentation from Amsterdam with a panel discussion in Barcelona, DRUGS TODAY, 35, 1999, pp. 149-159
Authors:
Liu, ZJ
Colpaert, S
D'Haens, GR
Kasran, A
de Boer, M
Rutgeerts, P
Geboes, K
Ceuppens, JL
Citation: Zj. Liu et al., Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production, J IMMUNOL, 163(7), 1999, pp. 4049-4057
Authors:
D'Haens, G
Geboes, K
Rutgeerts, P
Citation: G. D'Haens et al., Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine, GASTROIN EN, 50(5), 1999, pp. 667-671
Authors:
Rutgeerts, P
Wang, TH
Llorens, PS
Citation: P. Rutgeerts et al., Gastrointestinal endoscopy and the patient with a risk of bleeding disorder, GASTROIN EN, 49(1), 1999, pp. 134-135
Authors:
Rutgeerts, P
D'Haens, G
Targan, S
Vasiliauskas, E
Hanauer, SB
Present, DH
Mayer, L
Van Hogezand, RA
Braakman, T
DeWoody, KL
Schaible, TF
Van Deventer, SJH
Citation: P. Rutgeerts et al., Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease, GASTROENTY, 117(4), 1999, pp. 761-769
Authors:
D'Haens, G
Van Deventer, S
Van Hogezand, R
Chalmers, D
Kothe, C
Baert, F
Braakman, T
Schaible, T
Geboes, K
Rutgeerts, P
Citation: G. D'Haens et al., Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial, GASTROENTY, 116(5), 1999, pp. 1029-1034
Authors:
Hellers, G
Cortot, A
Jewell, D
Leijonmarck, CE
Lofberg, R
Malchow, H
Nilsson, LG
Pallone, F
Pena, S
Persson, T
Prantera, C
Rutgeerts, P
Citation: G. Hellers et al., Oral budesonide for prevention of postsurgical recurrence in Crohn's disease, GASTROENTY, 116(2), 1999, pp. 294-300
Authors:
Rutgeerts, P
Baert, F
Citation: P. Rutgeerts et F. Baert, New strategies in the management of inflammatory bowel disease., ACT CLIN B, 54(5), 1999, pp. 274-280
Authors:
Rutgeerts, P
Baert, F
Citation: P. Rutgeerts et F. Baert, Immunosuppressive drugs in the treatment of Crohn's disease, EURO J SURG, 164(12), 1998, pp. 911-915